Needleless Ebola vaccine succeeds in monkeys; Vanderbilt University Medical Center becomes first scientific hub for Human Vaccines Project;

> The University of Texas Medical Branch at Galveston and the NIH tested an inhaled Ebola vaccine, which showed promise in monkeys and should move into human trials soon. Story

> Vanderbilt University Medical Center has become the first scientific hub for the Human Vaccines Project, incubated by the International AIDS Vaccine Initiative. Release

> Researchers at the University of Georgia have developed new tools to study the parasite that causes cryptosporidiosis. They hope to use them to develop treatments and vaccines for the disease. More

Suggested Articles

Amid the COVID-19 pandemic, many teams of researchers are working on potential vaccines. We asked experts to assess progress—and point out challenges.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.